AURION BIOTECHNOLOGIES
Based in Seattle, Boston and Tokyo, Aurion Biotech is a clinical-stage biotech company. Our mission is to cure leading forms of blindness and transform the lives of millions of patients, by developing a platform of advanced therapies to treat ocular diseases. Our first candidate is for the treatment of corneal edema, and one of the first clinically validated cell therapies for corneal care. Healthy cells from a donor cornea are cultured in a novel, multi-step, proprietary and patented process. Cells from a single donor can be used to treat more than 100 recipient eyes. In clinical trials in Japan, patients have experienced significant and durable improvements in key measures of corneal health: visual acuity, corneal endothelial cell density and corneal thickness.
AURION BIOTECHNOLOGIES
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2021-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.aurionbiotech.com
Total Employee:
11+
Status:
Active
Contact:
+1 4159712900
Total Funding:
120 M USD
Technology used in webpage:
Euro Cloudflare Hosting Person Schema Gravatar Profiles
Similar Organizations
Anagenesis
Anagenesis is a preclinical‐stage stem cell-based company.
AXIM Biotechnologies
AXIM Biotechnologies is an innovative biotechnology company.
Caelum Biosciences
Caelum Biosciences, Inc.is a clinical-stage biotechnology company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
DeuterOncology
DeuterOncology is a preclinical-stage biotech company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Medicell Technologies
MediCell Technologies is a biotechnology company.
Protein Technologies
Protein Technologies Ltd. (PTL) is an award-winning, biotech company.
RiboMed Biotechnologies
RiboMed Biotechnologies is a molecular diagnostic company.
Vivid Biosciences
Vivid Biosciences is a clinical-stage biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Visionary Venture Fund
Visionary Venture Fund investment in Venture Round - Aurion Biotechnologies
Alcon
Alcon investment in Venture Round - Aurion Biotechnologies
Petrichor Healthcare Capital Management
Petrichor Healthcare Capital Management investment in Venture Round - Aurion Biotechnologies
Deerfield
Deerfield investment in Venture Round - Aurion Biotechnologies
Falcon Vision
Falcon Vision investment in Venture Round - Aurion Biotechnologies
Flying L Partners
Flying L Partners investment in Venture Round - Aurion Biotechnologies
Key Employee Changes
| Date | New article |
|---|---|
| 2022-12-07 | Aurion Biotech Appoints Jonathan Sparks, JD, PhD as Chief Legal Officer |
Official Site Inspections
http://www.aurionbiotech.com Semrush global rank: 3.42 M Semrush visits lastest month: 3.97 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aurion Biotechnologies"
Aurion Biotech - LinkedIn
Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal …See details»
Aurion Biotechnologies - Crunchbase Company Profile & Funding
Based in Seattle, Boston and Tokyo, Aurion Biotech is a clinical-stage biotech company. Our mission is to cure leading forms of blindness and transform the lives of millions of patients, by …See details»
Aurion Biotech 2025 Company Profile: Valuation, Investors
Aurion Biotech General Information Description. Aurion Biotech Inc is a clinical-stage biotechnology company committed to developing and commercializing disease-modifying, …See details»
AURION BIOTECH, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AURION BIOTECH, INC. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Aurion Biotech (USA) Funding: $120M - medicalstartups.org
Mar 11, 2025 Aurion Biotechnologies is on mission is to cure leading forms of blindness and transform the lives of millions of patients, by developing a platform of advanced therapies to …See details»
Aurion Biotech - 2025 Company Profile - Tracxn
Mar 29, 2025 Aurion Biotech has raised a total funding of $120M over 1 round. Its latest funding round was a Series C round on Apr 12, 2022 for $120M. 7 investors participated in its latest …See details»
Aurion Biotech, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Aurionbiotech.com. Holding Company | 2021 | Washington, United States | aurionbiotech.com. Last update 30 Jan 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. ... The …See details»
Aurion Biotech - Craft
Aurion Biotech has 5 employees at their 1 location and $120 m in total funding,. See insights on Aurion Biotech including office locations, competitors, revenue, financials, executives, …See details»
Aurion Biotech - Leadership Team - The Org
The Leadership Team at Aurion Biotech is responsible for setting the strategic direction and vision of the company. This team, comprised of executives from key functional areas such as clinical …See details»
Aurion Biotechnologies
Aurion Biotechnologies is a clinical-stage biotechnology company focused on developing innovative, accessible, and effective advanced therapies for ocular diseases. Their mission is …See details»
Aurion’s lead clinical candidate is a cell therapy for treating corneal ...
Oct 5, 2021 Aurion Biotech, which specializes in advanced therapies to treat eye diseases, recently appointed Tim Largen as VP of manufacturing to manage theSee details»
Aurion Biotech - Overview, News & Similar companies - ZoomInfo
May 16, 2024 Aurion Biotech Announces Completion of Enrollment in Phase 1 / 2 Clinical Trial SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, whose …See details»
Aurion Biotech Inc. - MassBio
Massachusetts Biotechnology Council. 700 Technology Square, 5th Floor Cambridge, MA 02139 617.674.5100See details»
Aurion Biotech Announces Strategic Investments in Manufacturing
Sep 14, 2021 To learn more about Aurion Biotech, a division of CorneaGen Inc., visit www.aurionbiotech.com Contacts Judith McGarry 415-971-2900 …See details»
Aurion Biotech Named to - Business Wire
Mar 18, 2025 Judith McGarry (corporate communications) 415-971-2900 [email protected] Michele Gray (ophthalmology media) 917-449-9250 …See details»
Aurion Biotech Receives Breakthrough Therapy Designation and ...
Jun 19, 2024 Judith McGarry (corporate communications) 415-971-2900 [email protected] Beth Keshishian (biotech & business media) 917-912-7195 …See details»
Ophthalmology - aurionbiotech.com
Oct 15, 2021 special report EXPLORATORY TRIALS IN CELL THERAPY OphthalmologyTimes.com OCTOBER 15, 2021 2020 to May 2021, at the Clínica Quesada in …See details»
Aurion Biotech Company Overview, Contact Details & Competitors …
Apr 12, 2022 Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced it has been selected as "Regenerative …See details»
Aurion Biotech raises $120M for 'global transformation in the …
Apr 12, 2022 Aurion Biotech is setting its sights high with a mission to restore vision for millions of patients via regenerative therapies and a $120 million financing round to back the tech.. The …See details»
Aurion Biotech Named to Fast Company’s Annual List of
Mar 18, 2025 [email protected]. Michele Gray (ophthalmology media) 917-449-9250 [email protected]. Beth Keshishian (biotech & business media) …See details»